col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


207 Results       Page 1

 [1] 
Elsevier: European Journal of Internal Medicine
  original article Date Title Authors   All Authors
1 [GO] 2023―Mar―22 Differences in reporting of adverse drug reactions due to COVID-19 vaccines depending on the reporter Alfredo Jose Pardo-Cabello, Victoria Manzano-Gamero, Juan de Dios Luna
2 [GO] 2023―Mar―21 Clinical pearls and pitfalls of SARS-CoV-2 serology Giuseppe Lippi, Brandon M. Henry
3 [GO] 2023―Mar―06 The relationship between COVID-19 vaccines and increased blood pressure: a word of caution Giacomo Buso, Claudia Agabiti-Rosei, Maria Lorenza Muiesan
4 [GO] 2023―Feb―20 Lung ultrasound must be the first-line image technique in COVID-19 patients Juan Torres-Macho, Miguel Angel Casado-Suela, Mercedes Duffort-Falcó
5 [GO] 2023―Feb―17 Intravenous pulse methylprednisolone for the treatment of severe COVID-19 Dimitrios Patoulias, Athina Dimosiari
6 [GO] 2023―Feb―16 Colchicine and mortality outcomes in patients with coronavirus disease (COVID-19) Mohammed I. Danjuma, Ridhima Kaul, Tamader Alyaarabi, Basant Elsayed, Mohamed Elshafei
7 [GO] 2023―Feb―13 Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe Alfredo Jose Pardo-Cabello, Victoria Manzano-Gamero, Juan de Dios Luna
8 [GO] 2023―Feb―09 Evolution of the SARS-CoV-2 epidemic: From genomic surveillance to new health needs Andrea Giacomelli, Anna Lisa Ridolfo, Letizia Oreni, Giuliano Rizzardini, Spinello Antinori
9 [GO] 2023―Jan―25 The impact of atrial fibrillation on outcomes in patients hospitalized with COVID-19 Siddharth Agarwal, Muhammad Bilal Munir, Stavros Stavrakis, Jonathan P Piccini, Zain Ul Abideen Asad
10 [GO] 2023―Jan―05 Outcomes of Patients with Cardiac Arrest with and without COVID-19 in the United States Agam Bansal, Mohammed Faisaluddin, Raunak Nair, Siddharth Agarwal
11 [GO] 2023―Jan―05 Characteristics and outcomes of unvaccinated and vaccinated COVID-19 patients with acute respiratory failure treated with CPAP in a medical intermediate care unit Silvia Accordino, Ciro Canetta, Francesco Blasi
12 [GO] 2022―Dec―27 Serological testing for SARS-CoV-2: Advancements and future challenges Harry Alexopoulos, Ioannis P Trougakos, Meletios-Athanasios Dimopoulos, Evangelos Terpos
13 [GO] 2022―Dec―16 Timeline analysis of clinical severity of COVID-19 in the general population Camilla Mattiuzzi, Giuseppe Lippi
14 [GO] 2022―Dec―13 The spike effect of acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 vaccines on blood pressure Fabio Angeli, Martina Zappa, Gianpaolo Reboldi, Giorgio Gentile, Monica Trapasso, Antonio Spanevello, Paolo Verdecchia
15 [GO] 2022―Dec―08 Long-term lung ultrasound follow-up in patients after COVID-19 pneumonia hospitalization: a prospective comparative study with chest computed tomography Greta Barbieri, Luna Gargani, Vittoria Lepri, Stefano Spinelli, Chiara Romei, Annalisa De Liperi, et al. (+5)
16 [GO] 2022―Dec―05 Trend in the proportion of subjects with SARS-CoV-2 infection without COVID-19 specific symptoms among patients admitted to a COVID-19 referral hospital Andrea Giacomelli, Anna Lisa Ridolfo, Letizia Oreni, Giuliano Rizzardini, Spinello Antinori
17 [GO] 2022―Dec―02 Lack of efficacy of Interferon β-1a in COVID-19 patients with mild to moderate pneumonia Carlo Bosi, Roberto Ferrarese, Rebecca De Lorenzo, Nicasio Mancini, Emanuele Bosi
18 [GO] 2022―Nov―30 Reshaping care in the aftermath of the pandemic. Implications for cardiology health systems Antonio Jordan-Rios, Vincenzo Nuzzi, Daniel I Bromage, Theresa McDonagh, Gianfranco Sinagra, Antonio Cannata
19 [GO] 2022―Nov―23 Aspirin and P2Y12 inhibitors in treating COVID-19 Amirmohammad Khalaji, Amir Hossein Behnoush, Soheil Peiman
20 [GO] 2022―Nov―23 Reliability of SARS-CoV-2 serological testing for influencing public health policies: A reappraisal Giuseppe Lippi, Mario Plebani
21 [GO] 2022―Nov―17 Hypertension and mortality in SARS-COV-2 infection: A meta-analysis of observational studies after 2 years of pandemic Lanfranco D'Elia, Alfonso Giaquinto, Aquilino Flavio Zarrella, Domenico Rendina, Paola Iaccarino Idelson, Pasquale Strazzullo, Ferruccio Galletti
22 [GO] 2022―Nov―16 Safety and efficacy of interleukin-1 antagonists in hospitalized patients with COVID-19. Athina Dimosiari, Dimitrios Patoulias, Ioannis Pantazopoulos, Epaminondas Zakynthinos, Demosthenes Makris
23 [GO] 2022―Nov―10 Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodies Harry Alexopoulos, Ioannis P Trougakos, Meletios-Athanasios Dimopoulos, Evangelos Terpos
24 [GO] 2022―Nov―07 The new phase of pandemic: Are BA.2.75 and BQ.1 competitive variants? An in silico evaluation Martina Zappa, Paolo Verdecchia, Fabio Angeli
25 [GO] 2022―Oct―31 Treatment with COLchicine in hospitalized patients affected by COVID-19: the COLVID-19 trial Carlo Perricone, Mirko Scarsi, Antonio Brucato, Paola Pisano, Erika Pigatto, Cecilia Becattini, et al. (+34)
26 [GO] 2022―Oct―21 Influence of vaccination and immunosuppressive treatments on the coronavirus disease 2019 outcomes in patients with systemic autoimmune diseases Jorge Álvarez-Troncoso, Lucía López-Caballero, Ángel Robles-Marhuend, Clara Soto-Abánades, Juan José Ríos-Blanco
27 [GO] 2022―Oct―06 Liver injury with autoimmune features after vaccination against SARS-CoV-2: the verdict is still open Marco Ferronato, Marco Lenzi, Luigi Muratori
28 [GO] 2022―Oct―03 ‘Paperdemic’ during the COVID-19 pandemic Yang Yang, Na Zhao, Ting Ma, Ze Yuan, Cheng Deng
29 [GO] 2022―Sep―21 Corrigendum to ‘External validation of risk scores to predict in-hospital mortality in patients hospitalized due to coronavirus disease 2019’ Shermarke Hassan, Chava L. Ramspek, Barbara Ferrari, Merel van Diepen, Raffaella Rossio, Rachel Knevel, et al. (+11)
30 [GO] 2022―Sep―19 Harm of early dexamethasone for COVID-19 and bias in randomized trials Isaac Núñez, Yanink Caro-Vega, Adrian Soto-Mota
31 [GO] 2022―Sep―01 Non-invasive respiratory supports on inspiratory effort in COVID-19: How and when is it matter of selection? Author's reply. Gioacchino Schifino, Maria Laura Vega, Lara Pisani, Stefano Nava
32 [GO] 2022―Aug―24 In COVID-19 patients with mild or moderate respiratory failure, duration and type of symptoms influence the diagnostic accuracy of lung ultrasound Pawlowska Victoria, Coucke Christophe, Noirez Leslie, Papadimitriou-Olivgeris Matthaios, Monti Matteo
33 [GO] 2022―Aug―23 COVID-19 vaccines effect on blood pressure Marco Simonini, Maria Giovanna Scarale, Francesca Tunesi, Matteo Moro, Clelia Di Serio, Paolo Manunta, Chiara Lanzani
34 [GO] 2022―Aug―22 Non-invasive respiratory supports on inspiratory effort in Covid-19: how and when is it matter of selection? Martina Flora, Mariano Mollica, Giuseppe Fiorentino, Antonio M. Esquinas
35 [GO] 2022―Aug―18 Angiographic and clinical outcome of SARS-CoV-2 positive patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: A collaborative, individual patient data meta-analysis of six registry-based studies Giuseppe De Luca, Angelo Silverio, Monica Verdoia, Zbigniew Siudak, Tomasz Tokarek, Thomas A. Kite, et al. (+9)
36 [GO] 2022―Aug―16 A Reappraisal of Corticosteroids use for COVID-19 Ilaria Pati, Francesca Masiello, Simonetta Pupella, Mario Cruciani, Vincenzo De Angelis
37 [GO] 2022―Aug―12 Structural evolution of severe acute respiratory syndrome coronavirus 2: implications for adhesivity to angiotensin-converting enzyme 2 receptors and vaccines Martina Zappa, Paolo Verdecchia, Antonio Spanevello, Fabio Angeli
38 [GO] 2022―Aug―01 Varicella-Zoster virus reactivation following severe acute respiratory syndrome coronavirus 2 vaccination or infection: New insights Raquel Martinez-Reviejo, Sofia Tejada, Ganiyat A.R. Adebanjo, Camilla Chello, Miriam C. Machado, Francesca R. Parisella, et al. (+3)
39 [GO] 2022―Jul―18 COVID-19 mRNA vaccination in patients with previous myocarditis Maurizio Pieroni, Michele Ciabatti, Elisa Saletti, Emanuele D'Aniello, Leonardo Bolognese
40 [GO] 2022―Jul―18 The COVID-19 pandemic - How many times were we warned before? Naim Mahroum, Isa Seida, Sevval Nil Esirgün, Nicola Luigi Bragazzi
41 [GO] 2022―Jun―28 Participants’ informed consent in adaptive, platform drug trials in hospitalized COVID-19 patients: Not all approaches are ethically acceptable Rafael Dal-Ré, Arthur L Caplan, Teck Chuan Voo
42 [GO] 2022―Jun―22 COVID-19, vaccines and deficiency of ACE2 and other angiotensinases. Closing the loop on the "Spike effect" Fabio Angeli, Gianpaolo Reboldi, Monica Trapasso, Martina Zappa, Antonio Spanevello, Paolo Verdecchia
43 [GO] 2022―Jun―20 Durable functional limitation in patients with coronavirus disease-2019 admitted to intensive care and the effect of intermediate-dose vs standard-dose anticoagulation on functional outcomes
44 [GO] 2022―Jun―17 Supine vs prone position in mild to moderate COVID-19 pneumonia: the impact of proning on computed tomography findings S Piciucchi, ML Garo, S Tomassetti, C Ravaglia, V Poletti
45 [GO] 2022―Jun―16 Blood pressure increase during hospitalization for COVID-19 Fabio Angeli, Martina Zappa, Federico Mattia Oliva, Antonio Spanevello, Paolo Verdecchia
46 [GO] 2022―Jun―09 Effects of statins on clinical outcomes in hospitalized patients with COVID-19 Paulo Ricardo Martins-Filho, José Augusto Soares Barreto-Filho, Antônio Carlos Sobral Sousa
47 [GO] 2022―Jun―08 External validation of risk scores to predict in-hospital mortality in patients hospitalized due to coronavirus disease 2019 Shermarke Hassan, Chava L. Ramspek, Barbara Ferrari, Merel van Diepen, Raffaella Rossio, Rachel Knevel, et al. (+11)
48 [GO] 2022―Jun―06 Trends of thrombo-inflammation biomarkers after Tocilizumab predict treatment failure better than scores in patients with severe SARS-CoV2 related respiratory failure Luca Masotti, Elisa Cioni, Elisa Grifoni, Francesco Cei, Roberto Tarquini
49 [GO] 2022―Jun―03 T-cell immune response predicts the risk of critical SARS-Cov2 infection in hospitalized COVID-19 patients Maxime Samson, Barbara Nicolas, Alexandre Guilhem, Hélène Greigert, Marion Ciudad, Claudie Cladiere, et al. (+11)
50 [GO] 2022―May―30 Syndrome of inappropriate antidiuresis as a maladaptive stress response shared by coronavirus disease 2019 and other cytokine storm disorders Lorenzo Muccioli, Umberto Pensato, Maria Guarino, Francesca Bisulli, Marco Faustini Fustini
51 [GO] 2022―May―26 Personal protective equipment portraits in the era of COVID-19 Christopher Hansen-Barkun, Omar Kherad, Adamo A Donovan, Anupa J Prashad, Maida J Sewitch
52 [GO] 2022―May―26 The Omicron wave and the waning of COVID-19 vaccine effectiveness. Influence of vaccine booster and age on confirmed infection incidence Luis Corral-Gudino, María Piedad Del-Amo-Merino, José María Eiros-Bouza, Jesús Fernando García-Cruces-Méndez, Marta Domínguez-Gil González
53 [GO] 2022―May―25 Efficacy and safety of molnupiravir for COVID-19 patients Maurish Fatima, Saleha Azeem, Junaid Saeed, Abia Shahid, Huzaifa Ahmad Cheema
54 [GO] 2022―May―12 Treatment strategies of Covid-19. A rheumatology perspective. Alexandros A. Drosos, Eleftherios Pelechas, Paraskevi V. Voulgari
55 [GO] 2022―Apr―25 Interleukin 6 inhibition in severe COVID-19: another piece of the puzzle Nicola Farina, Lorenzo Dagna
56 [GO] 2022―Apr―22 Effects of Non-Invasive Respiratory Supports on inspiratory effort in moderate-severe COVID-19 patients. A randomized physiological study. Gioacchino Schifino, Maria L Vega, Lara Pisani, Irene Prediletto, Vito Catalanotti, Vittoria Comellini, et al. (+4)
57 [GO] 2022―Apr―14 Experience with procalcitonin use during the COVID-19 pandemic Laura Gonzalez, Thomas Holman, Daniel Waite, Pearl Abenojar
58 [GO] 2022―Apr―13 Anticoagulation as secondary prevention of massive lung thromboses in hospitalized patients with COVID-19 Rosaria Sofia, Mattias Carbone, Giovanni Landoni, Alberto Zangrillo, Lorenzo Dagna
59 [GO] 2022―Apr―07 Interleukin-6 inhibitors reduce mortality in coronavirus disease-2019: An individual patient data meta-analysis from randomized controlled trials Panagiotis T. Tasoudis, Christina K. Arvaniti, Anastasia T. Adamou, Ioannis Belios, John H. Stone, Nora Horick, et al. (+3)
60 [GO] 2022―Mar―16 The role of heparin in reducing in-hospital complications and three-month mortality rates in hospitalized COVID-19 patients F. Calabretta, P.S. Preti, M. Russo, C. Klersy, A. Di Sabatino
61 [GO] 2022―Mar―14 Physical decline and cognitive impairment in frail hypertensive elders during COVID-19 Pasquale Mone, Antonella Pansini, Salvatore Frullone, Antonio de Donato, Veronica Buonincontri, Paolo De Blasiis, et al. (+4)
62 [GO] 2022―Mar―14 Doubtful clinical benefit of casirivimab-imdevimab treatment for disease severity outcome of high-risk patients with SARS-CoV-2 delta variant infection Noah Shopen, Michal Dekel, Michal Mizrahi, Efrat Zandberg, Daniel Talmud, Neta Cohen
63 [GO] 2022―Mar―11 The Precautionary Principle in the COVID-19 vaccination campaign: the complicated relationship between the scientific community, medicines regulatory agencies and citizens Lobello Paola Aurora, Squizzato Alessandro, Picozzi Mario
64 [GO] 2022―Mar―09 “Thrombotic events following Covid-19 vaccines compared to Influenza vaccines.” Marcelo Gabriel Vallone, Andre Luis Falcón, Horacio Matias Castro, Augusto Ferraris, Ramiro Francisco Cantarella, María Inés Staneloni, et al. (+5)
65 [GO] 2022―Feb―14 Double-gloving in an Intensive Care Unit during the COVID-19 pandemic Ori Galante, Abraham Borer, Yaniv Almog, Lior Fuchs, Lisa Saidel-Odes
66 [GO] 2022―Feb―14 Is the number of long-term post-COVID symptoms relevant in hospitalized COVID-19 survivors? César Fernández-de-las-Peñas, Umut Varol, Stella Fuensalida-Novo, Susana Plaza-Canteli, Juan Antonio Valera-Calero
67 [GO] 2022―Feb―14 Reduced COVID-19 mortality linked with early antibodies against SARS-CoV-2, irrespective of age Danila De Vito, Agostino Di Ciaula, Vincenzo O. Palmieri, Paolo Trerotoli, Angela Maria Vittoria Larocca, Maria Teresa Montagna, Piero Portincasa
68 [GO] 2022―Feb―03 Acute coronary syndromes during the first and the second wave of COVID-19 Marco Ferlini, Diego Castini, Luigi Oltrona Visconti, Stefano Carugo
69 [GO] 2022―Jan―31 Usefulness of non-invasive methods for the monitoring of oxygenation parameters in patients with COVID-19 associated ARDS Diego Alberto Pérez Pinzón, Cristin Camilo Villa Gómez, Julio Andrés Boada Garnica, Marlon Adrián Laguado Nieto
70 [GO] 2022―Jan―28 Pulmonary embolism severity and in-hospital mortality: An international comparative study between COVID-19 and non-COVID patients Òscar Miró, Sònia Jiménez, Pere Llorens, Melanie Roussel, Judith Gorlicki, Eric Jorge García-Lamberechts, et al. (+10)
71 [GO] 2022―Jan―24 T-cell response to 3 doses of Sars-Cov2 BNT162b2 Pfizer vaccine in long term rituximab treated patients Jade Heitz, Jerome Razanamahery, Sylvain Audia, Jean-Baptiste Bour, Julien Guy, Sabine Berthier, et al. (+5)
72 [GO] 2022―Jan―21 Efficacy and safety of therapeutic vs. prophylactic bemiparin in noncritically ill patients with COVID-19 pneumonia. Jose F Varona, Elena Núñez, Borja M. Fernández Félix, Jose María Castellano Vázquez, Antonio Cubillo
73 [GO] 2022―Jan―12 COVID-19 Infection Survivors and the Risk of Depression and Anxiety Symptoms: A Nationwide Study of Adults in the United States Jagdish Khubchandani, James H. Price, Sushil Sharma, Fern J. Webb
74 [GO] 2022―Jan―10 Return to work after hospitalisation for COVID-19 infection Orlando Hürlimann, Pierre Decavel, Jean-Marie Annoni, Marco Mancinetti
75 [GO] 2022―Jan―07 Convalescent plasma for COVID-19. TSUNAMI is not the final word Massimo Franchini, Daniele Focosi, Arturo Casadevall, Michael J. Joyner, Cesare Perotti
76 [GO] 2022―Jan―05 SARS-CoV-2 antibody response eight months after vaccination with mRNA vaccines. Influence of prior SARS-CoV-2 exposure Jesús Fernando García-Cruces-Méndez, Luis Corral-Gudino, María Piedad Del-Amo-Merino, José María Eiros-Bouza, Marta Domínguez-Gil González
77 [GO] 2021―Dec―21 CORRELATION OF NON-INVASIVE OXYGENATION PARAMETERS WITH paO2/FiO2 RATIO IN PATIENTS WITH COVID-19 ASSOCIATED ARDS Giacomo Zaccagnini, Andrea Berni, Filippo Pieralli
78 [GO] 2021―Dec―21 The relevance of nutritional and metabolic derangements in COVID-19 patients Alessio Molfino, Giovanni Imbimbo, Maurizio Muscaritoli
79 [GO] 2021―Dec―07 Factors associated with persistence of symptoms 1 year after COVID-19: a longitudinal, prospective phone-based interview follow-up cohort study Carlo Fumagalli, Chiara Zocchi, Luigi Tassetti, Maria Vittoria Silverii, Carla Amato, Luca Livi, et al. (+11)
80 [GO] 2021―Nov―29 Short term Blood Pressure Alterations in Recently COVID-19 Vaccinated Patients Elias Sanidas, Theoharis Anastasiou, Dimitrios Papadopoulos, Maria Velliou, Marina Mantzourani
81 [GO] 2021―Nov―25 Colchicine for the prevention of COVID-19 “hard” outcomes: all that glitters is not gold Dimitrios Patoulias, Christodoulos Papadopoulos, Asterios Karagiannis, Michael Doumas
82 [GO] 2021―Nov―22 Tocilizumab in severe COVID-19: A promise fulfilled Marcel Levi
83 [GO] 2021―Nov―13 Colchicine for COVID-19: hype or hope? Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
84 [GO] 2021―Nov―12 Learning in times of stress: lessons from COVID-19 that will last throughout this century. Paula Jiménez-Fonseca, Ramón Salazar, Vicent Valentí, Alberto Carmona-Bayonas, Giancarlo Agnelli
85 [GO] 2021―Nov―11 Anakinra in COVID-19: A step closer to the cure Fotios Barkas, Eirini Christaki, Evangelos Liberopoulos, Maria Kosmidou, Haralampos Milionis
86 [GO] 2021―Nov―11 Anticoagulant therapy for COVID-19: What we have learned and what are the unanswered questions? Dimitrios Giannis, James D. Douketis, Alex C. Spyropoulos
87 [GO] 2021―Oct―27 Hydroxichloroquine for COVID-19 infection: do we have a final word after one year? Dr. Augusto Di Castelnuovo, Simona Costanzo, Alessandro Gialluisi, Licia Iacoviello, Giovanni de Gaetano
88 [GO] 2021―Oct―27 Humoral SARS-COV-2 IgG decay within 6 months in COVID-19 healthy vaccinees: The need for a booster vaccine dose? Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, Gil Harari, Michael Gurevich
89 [GO] 2021―Oct―25 One year later: The case of tocilizumab in COVID-19 Corrado Campochiaro, Alessandro Tomelleri, Marco Matucci-Cerinic, Lorenzo Dagna
90 [GO] 2021―Oct―25 Standardized PaO2/FiO2 ratio in COVID-19: added Added value or risky assumption. Author's reply Irene Prediletto, Stefano Nava, Paolo Palange
91 [GO] 2021―Oct―25 Predicting adverse outcomes in patients with COVID-19: just an epidemiological debate or a valuable clinical approach? Xavier Corbella
92 [GO] 2021―Oct―22 Serum IgG4 elevation in hyper-inflamed COVID-19 patients. Author's reply Emanuel Della-Torre, Marco Lanzillotta, Giuseppe Alvise Ramirez, Lorenzo Dagna, Moreno Tresoldi
93 [GO] 2021―Oct―19 COVID-19 vaccination and a severe pain in the neck Angelos Kyriacou, Stamatina Ioakim, Akheel A. Syed
94 [GO] 2021―Oct―15 Electrocardiographic Features of Patients with COVID-19: One Year of Unexpected Manifestations Fabio Angeli, Gianpaolo Reboldi, Antonio Spanevello, Roberto De Ponti, Dina Visca, Jacopo Marazzato, et al. (+5)
95 [GO] 2021―Oct―12 Cardiopulmonary exercise test with stress echocardiography in COVID-19 survivors at 6 months follow-up Luca Vannini, Alejandro Quijada-Fumero, M Purificación Ramirez Martín, Nuria Castejón Pina, Julio S. Hernandez Afonso
96 [GO] 2021―Sep―24 Serum IgG4 level predicts COVID-19 related mortality Emanuel Della-Torre, Marco Lanzillotta, Marta Strollo, Giuseppe Alvise Ramirez, Lorenzo Dagna, Moreno Tresoldi
97 [GO] 2021―Sep―23 The coupling between sarcopenia and COVID-19 is the real problem Rizwan Qaisar, Asima Karim, Tahir Muhammad, Islam Shah, M. Shahid Iqbal
98 [GO] 2021―Sep―20 The Pivotal Link Between ACE2 Deficiency and SARS-CoV-2 Infection: One Year Later Fabio Angeli, Martina Zappa, Gianpaolo Reboldi, Monica Trapasso, Claudio Cavallini, Antonio Spanevello, Paolo Verdecchia
99 [GO] 2021―Sep―09 Standardised PaO2/FiO2 ratio in COVID-19: added value or risky assumptions? Luciano Gattinoni, Mattia Busana, Luigi Camporota
100 [GO] 2021―Sep―09 Vitamin D deficiency and inactivated SARS-CoV-2 vaccines Chia-Chao Wu, Kuo-Cheng Lu
101 [GO] 2021―Sep―02 Long term consequences of COVID-19 Anna Berenguera
102 [GO] 2021―Aug―30 Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care. Lucia Taramasso, Laura Magnasco, Federica Portunato, Federica Briano, Antonio Vena, Daniele R. Giacobbe, et al. (+11)
103 [GO] 2021―Aug―28 EXPLORING THE POSSIBLE LINK BETWEEN MYOCARDITIS AND mRNA COVID-19 VACCINES Gianfranco Sinagra, Marco Merlo, Aldostefano Porcari
104 [GO] 2021―Aug―25 One year on: the impact of COVID-19 on clinical research Luigi Tavazzi, Aldo P Maggioni, Claudio Rapezzi, Roberto Ferrari
105 [GO] 2021―Aug―16 SARCOPENIC OBESITY IS THE REAL PROBLEM IN COVID-19 ! Murat Kara, Ayşe Merve Ata, Levent Özçakar
106 [GO] 2021―Aug―16 Examination of the relationship between emergency department presentations and population mortality: a multicenter analysis of emergency department presentations during the COVID-19 pandemic Monica Solbiati, Lorenzo Russo, Anna Beverina, Paolo Groff, Andrea Strada, Ludovico Furlan, et al. (+3)
107 [GO] 2021―Aug―16 ChAdOx1 nCoV-19 EFFECTIVENESS DURING AN UNPRECEDENTED SURGE IN SARS COV-2 INFECTIONS Ruma Satwik, Ambarish Satwik, Satendra Katoch, Satish Saluja
108 [GO] 2021―Jul―10 Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT) Jose F. Varona, Millán García-Isidro, Mojdeh Moeinvaziri, María Ramos-López, Manuel Fernández-Domínguez
109 [GO] 2021―Jul―02 The link between nutritional status and outcomes in COVID-19 patients in ICU: Is obesity or sarcopenia the real problem? Alessio Molfino, Giovanni Imbimbo, Veronica Rizzo, Maurizio Muscaritoli, Daniela Alampi
110 [GO] 2021―Jun―29 Vaccine-induced thrombotic thrombocytopenia, a rare but severe case of friendly fire in the battle against COVID-19 pandemic: what pathogenesis? Raimondo De Cristofaro, Maurizio Sanguinetti
111 [GO] 2021―Jun―24 Laryngotracheal aspiration test reduce the false negative rate in patients with suspected SARS-COV-2 pneumonia despite a negative nasopharyngeal swab Peiman Nazerian, Roberto M. Sacco, Monica Solbiati, Elena Targetti, Chiara Marta, Francesco Blasi, et al. (+6)
112 [GO] 2021―Jun―18 Mask-off Policy in the Shadow of Emerging Variants of SARS-COV-2 Abdolrazagh Hashemi Shahraki, Majid Vahed, Mehdi Mirsaeidi
113 [GO] 2021―Jun―17 Standardizing PaO2 for PaCO2 in P/F ratio predicts in-hospital mortality in acute respiratory failure due to Covid-19: a pilot prospective study Irene Prediletto, Letizia D Antoni, Paolo Carbonara, Federico Daniele, Roberto Dongilli, Roberto Flore, et al. (+7)
114 [GO] 2021―Jun―16 Prevalence of Post-COVID-19 Symptoms in Hospitalized and Non-Hospitalized COVID-19 Survivors: A Systematic Review and Meta-Analysis César Fernández-de-las-Peñas, Domingo Palacios-Ceña, Víctor Gómez-Mayordomo, Lidiane L Florencio, María L. Cuadrado, Gustavo Plaza-Manzano, Marcos Navarro-Santana
115 [GO] 2021―Jun―16 Blood Pressure Increase After Pfizer/BioNTech SARS-CoV-2 Vaccine: Pfizer/BioNTech SARS-CoV-2 Vaccine and Blood Pressure Martina Zappa, Paolo Verdecchia, Antonio Spanevello, Dina Visca, Fabio Angeli
116 [GO] 2021―Jun―12 LUNG ULTRASOUND IN COVID-19: INSIGHTS FROM THE FRONTLINE AND RESEARCH EXPERIENCES Chiara Cogliati, Frank Bosch, Yale Tung-Chen, Nick Smallwood, Juan Torres-Macho
117 [GO] 2021―Jun―05 Anakinra or tocilizumab for prevention of COVID-19 death? A big dilemma Dimitrios Patoulias, Athina Dimosiari, Theodoros Michailidis
118 [GO] 2021―May―25 Thrombosis with Thrombocytopenia Syndrome associated with viral vector COVID-19 vaccines Marco Cattaneo
119 [GO] 2021―May―25 SARS-CoV-2 vaccine-induced cerebral venous thrombosis Alfonso Ciccone
120 [GO] 2021―May―18 SARS-CoV-2 Antibody Kinetics Eight Months from COVID-19 Οnset: Persistence of Spike Antibodies but Loss of Neutralizing Antibodies in 24% of Convalescent Plasma Donors Evangelos Terpos, Dimitris Stellas, Margherita Rosati, Theodoros N. Sergentanis, Xintao Hu, Marianna Politou, et al. (+11)
121 [GO] 2021―May―14 Incident atrial fibrillation and its risk prediction in patients developing COVID-19:A machine learning based algorithm approachs Gregory Y.H. Lip, Ash Genaidy, George Tran, Patricia Marroquin, Cara Estes
122 [GO] 2021―Apr―30 Convalescent plasma in the management of COVID-19 pneumonia Ayman Elbadawi, Mina Shnoda, Maryrose Laguio-Vila, Mamas A. Mamas, Islam Y. Elgendy
123 [GO] 2021―Apr―30 Healthcare students: should they be prioritized for COVID-19 vaccination? Michele Augusto Riva, Maria Emilia Paladino, Michael Belingheri
124 [GO] 2021―Apr―30 SARS-CoV-2 Vaccines: Lights and Shadows Fabio Angeli, Antonio Spanevello, Gianpaolo Reboldi, Dina Visca, Paolo Verdecchia
125 [GO] 2021―Apr―20 Joint Effect of Heart Failure and Coronary Artery Disease on the Risk of Death during Hospitalization for COVID-19 Fabio Angeli, Jacopo Marazzato, Paolo Verdecchia, Antonella Balestrino, Claudio Bruschi, Piero Ceriana, et al. (+12)
126 [GO] 2021―Apr―08 Prevalence of proximal deep vein thrombosis in hospitalized COVID-19 patients Guillaume Reichert, Vincent Bunel, Dora Dreyfuss, Loukbi Saker, Antoine Khalil, Hervé Mal
127 [GO] 2021―Apr―02 nObesity as an Adipose tissue dysfunction disease and A Risk Factor for Infections - Covid-19 as a case study Landecho MF, Marin-Oto M, Recalde-Zamacona B, Bilbao I, Gema Frühbeck
128 [GO] 2021―Mar―27 Lessons from pathophysiology: Use of individualized combination treatments with immune interventional agents to tackle severe respiratory failure in patients with COVID-19 George N. Dalekos, Aggelos Stefos, Sarah Georgiadou, Vasiliki Lygoura, Anastasia Michail, George Ntaios, et al. (+8)
129 [GO] 2021―Mar―27 Intermediate Dose Thromboprophylaxis in SARS-CoV-2 related Venous Thrombo Embolism Zahra Haider, Kanendran Rajalingam, Tanveer Khalid, Dilip Oswal, Akshay Dwarakanath
130 [GO] 2021―Mar―20 The power of choice: Experimental evidence that freedom to choose a vaccine against COVID-19 improves willingness to be vaccinated Philipp Sprengholz, Sarah Eitze, Lars Korn, Regina Siegers, Cornelia Betsch
131 [GO] 2021―Mar―20 Pneumothorax/pneumomediastinum in non-intubated COVID-19 patients: differences between first and second Italian pandemic wave Diego Palumbo, Corrado Campochiaro, Alessandro Belletti, Alessandro Marinosci, Lorenzo Dagna, Alberto Zangrillo, Francesco De Cobelli
132 [GO] 2021―Mar―20 Pre-admission atrial fibrillation in COVID-19 patients: prevalence and clinical impact Vincenzo Russo, Angelo Silverio, Fernando Scudiero, Pierpaolo Di Micco, Marco Di Maio
133 [GO] 2021―Mar―20 When Is It Reasonable to Extrapolate During a Pandemic?: The Case of Broad UK Labeling for AstraZeneca COVID-19 Vaccine Rafael Dal-Ré, Rita Banzi
134 [GO] 2021―Mar―14 Loneliness that destroys and upsets: a lesson from and beyond COVID-19 Christian Bracco, Remo Melchio, Elena Migliore, Chiara Marrale, Luigi Fenoglio
135 [GO] 2021―Mar―07 USEFULNESS OF STEP DOWN UNITS TO MANAGE SURVIVORS OF CRITICAL COVID-19 PATIENTS Piero Ceriana, Michele Vitacca, Mara Paneroni, Stefano Belli, Nicolino Ambrosino
136 [GO] 2021―Feb―26 DNA genotyping of the ABO gene showed a significant association of the A-group (A1/A2 variants) with severe COVID-19. Juan Gómez, Guillermo M Albaiceta, Marta García-Clemente, José M. García-Gala, Eliecer Coto
137 [GO] 2021―Feb―26 Mid-term Prognostic Implication of hospitalized COVID-19 patients with Prior Heart Failure diagnosis Pau Llàcer, Luis Manzano, Cristina Fernández, Mari Carmen Moreno, Julio Núñez
138 [GO] 2021―Feb―26 Non-invasive respiratory support in the treatment of acute hypoxemic respiratory failure secondary to CoViD-19 related pneumonia Paolo Groff, Rodolfo Ferrari
139 [GO] 2021―Feb―15 DIAGNOSIS OF INFECTION BY SARS-COV-2: IS ONE MOLECULAR TEST ENOUGH? Antonella Mencacci, Maria Cristina Vedovati, Barbara Camilloni, Elio Cenci, Cecilia Becattini
140 [GO] 2021―Feb―06 Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies. Laura Pasin, Giulio Cavalli, Paolo Navalesi, Nicolò Sella, Giovanni Landoni, Andrey G. Yavorovskiy, et al. (+4)
141 [GO] 2021―Feb―05 “Let me choose my COVID-19 vaccine” Rafael Dal-Ré, Richard Stephens, Nadarajah Sreeharan
142 [GO] 2021―Feb―05 SARS-CoV-2 seroprevalence in the Vatican City State Massimo Ralli, Andrea Arcangeli, Paolo Maurizio Soave, Cristina Voglino, Fabio De-Giorgio
143 [GO] 2021―Jan―31 Assessing the Impact of Covid-19 on the Health of Geriatric Patients: the European GeroCovid Observational Study Caterina Trevisan, Susanna Del Signore, Stefano Fumagalli, Pietro Gareri, Alba Malara, Enrico Mossello, et al. (+7)
144 [GO] 2021―Jan―22 A systematic bias assessment of top-cited full-length original clinical investigations related to COVID-19 Islam Y. Elgendy, Nayef Nimri, Amr F. Barakat, Joseph Ibrahim, John Mandrola, Andrew Foy
145 [GO] 2021―Jan―02 Lung ultrasonography: a prognostic tool in non-ICU hospitalized patients with COVID-19 pneumonia. Casella Francesco, Barchiesi Marco, Leidi Federica, Russo Giulia, Casazza Giovanni, Valerio Giulia, et al. (+6)
146 [GO] 2021―Jan―01 Flying higher than politics: the goal of preventive medicine at the time of the COVID-19 pandemic Francesco M. Galassi, Michael E. Habicht, F. Donald Pate, Elena Varotto
147 [GO] 2020―Dec―29 Low influenza vaccination coverage among hospitalized COVID-19 patients in Milan: a gap to be urgently filled. Anna Lisa Ridolfo, Laura Milazzo, Andrea Giacomelli, Letizia Oreni, Catia Borriello, Spinello Antinori
148 [GO] 2020―Dec―21 NEWS2 is a valuable tool for appropriate clinical management of COVID-19 patients Marta Rigoni, Emanuele Torri, Giandomenico Nollo, Livia Delle Donne, Susanna Cozzio
149 [GO] 2020―Nov―30 How does SARS-CoV-2 targets the elderly patients? A review on potential mechanisms increasing disease severity. Annemieke Smorenberg, Edgar JG Peters, Paul LA van Daele, Esther J Nossent, Majon Muller
150 [GO] 2020―Nov―23 Hydroxychloroquine for COVID-19: Balancing contrasting claims Peter W. Horby, Jonathan Emberson
151 [GO] 2020―Nov―12 The COVID-19 burden for health care professionals: Results of a global survey Matthias Schneider, Martin Altersberger, Christina Binder, Christian Hengstenberg, Thomas Binder
152 [GO] 2020―Nov―09 End-Stage renal disease and 30-day mortality for adults with and without COVID-19 Stephanie L. Harrison, Benjamin J.R. Buckley, Elnara Fazio-Eynullayeva, Paula Underhill, Deirdre A. Lane, Gregory Y.H. Lip
153 [GO] 2020―Nov―03 Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19 Marcello Di Nisio, Nicola Potere, Matteo Candeloro, Antonella Spacone, Leonardo Pieramati, Giovanna Ferrandu, et al. (+7)
154 [GO] 2020―Oct―31 Temporal changes in co-morbidities and mortality in patients hospitalized for COVID-19 in Italy Fabio Angeli, Tiziana Bachetti
155 [GO] 2020―Oct―28 Large-scale use of hydroxychloroquine for COVID-19 confirms safety, if not effectiveness Giulio Cavalli, Lorenzo Dagna
156 [GO] 2020―Oct―23 Venous thromboembolism and COVID-19: mind the gap between clinical epidemiology and patient management Michela Giustozzi, Maria Cristina Vedovati, Giancarlo Agnelli
157 [GO] 2020―Oct―16 Does Hydroxychloroquine Reduce Mortality for COVID-19? Silvano GALLUS, Antonio CLAVENNA, Alessandra LUGO
158 [GO] 2020―Oct―15 DISEASE COURSE IN PATIENTS WITH SYSTEMIC AUTOIMMUNE DISEASES: INSIGHTS ON THE SAFETY OF IMMUNOSUPPRESSION DURING THE SARS-COV-2 OUTBREAK IN ITALY Benfaremo Devis, Perini Lucia, Marconi Valentina, Luchetti Michele Maria, Gabrielli Armando
159 [GO] 2020―Oct―06 Significant increase in the incidence of high-risk pulmonary embolism during the COVID-19 shutdown: The pandemic response causes serious collateral consequences Paul Gressenberger, Thomas Gary, Reinhard B. Raggam, Andrea Borenich, Marianne Brodmann
160 [GO] 2020―Sep―25 Change over time of COVID-19 hospital presentation in Northern Italy Giuseppe Patti, Marco Mennuni, Francesco Della Corte, Enrico Spinoni, Pier Paolo Sainaghi
161 [GO] 2020―Sep―22 COVID-19 randomized controlled trials in medRxiv and PubMed Yuki Kataoka, Shiho Oide, Takashi Ariie, Yasushi Tsujimoto, Toshi A. Furukawa
162 [GO] 2020―Sep―17 Incidence of acute pulmonary embolism in COVID-19 patients: Systematic review and meta-analysis. Loris Roncon, Marco Zuin, Stefano Barco, Luca Valerio, Giovanni Zuliani, Pietro Zonzin, Stavros V Konstantinides
163 [GO] 2020―Aug―25 Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study Augusto Di Castelnuovo, Simona Costanzo, Andrea Antinori, Nausicaa Berselli, Lorenzo Blandi, Raffaele Bruno, et al. (+100)
164 [GO] 2020―Aug―13 Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in COVID-19 patients treated with hydroxychloroquine/chloroquine: new case reports coming out Lucia De Franceschi, Enrico Costa, Francesco Dima, Matteo Morandi, Oliviero Olivieri
165 [GO] 2020―Jul―21 COVID-19 and hydroxychloroquine: Let the available data speak for themselves Ugo Paliani, Andrea Cardona
166 [GO] 2020―Jul―21 Italian Vò municipality cohort and COVID-19 epidemiology: The “Framingham” study of the 21st century Marco Zuin, Claudio Bilato, Giovanni Zuliani, Loris Roncon
167 [GO] 2020―Jul―09 Published evidence on COVID-19 in top-ranked journals: A descriptive study Juan M Pericàs, Andrea Arenas, Orla Torrallardona-Murphy, Helena Valero, David Nicolás
168 [GO] 2020―Jul―07 Romeo and Juliet: Revisited (at the time of COVID-19) Giorgio Costantino, Flora Peyvandi, Nicola Montano, Carlo Agostoni
169 [GO] 2020―Jul―07 Waste in COVID-19 clinical trials conducted in western Europe Rafael Dal-Ré, Ignacio Mahillo-Fernández
170 [GO] 2020―Jul―07 Linking hydroxychloroquine to hemolysis in a ‘suspected’ glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection - a critical appraisal T.P. Afra, Ram Vasudevan Nampoothiri, Muhammed Razmi T, N. A. Bishurul Hafi
171 [GO] 2020―Jun―28 First comes the A, then the B: what we learned from the COVID-19 outbreak Roberto Copetti, Giulia Amore, Carmine Cristiano Di Gioia, Daniele Orso
172 [GO] 2020―Jun―23 Chloroquine and COVID-19: A western medical and scientific drift? Matthieu Million, Yanis Roussel, Didier Raoult
173 [GO] 2020―Jun―20 Electrocardiographic features of patients with COVID-19 pneumonia Fabio Angeli, Antonio Spanevello, Roberto De Ponti, Dina Visca, Jacopo Marazzato, Giulia Palmiotto, et al. (+4)
174 [GO] 2020―Jun―13 No double-edged sword and no doubt about the relation between smoking and COVID-19 severity Silvano GALLUS, Alessandra LUGO, Giuseppe GORINI
175 [GO] 2020―Jun―12 Very low reporting rate of connective tissue diseases among coronavirus disease 2019 (Covid-19) patients and the renin-angiotensin system - An overlooked association? Alessandro Giollo, Giovanni Cioffi, Maurizio Rossini, Ombretta Viapiana, Giovanni De Simone
176 [GO] 2020―Jun―10 Management and outcomes of post-acute COVID-19 patients in Northern Italy Michele Vitacca, Giovanni Battista Migliori, Antonio Spanevello, Mario Giovanni Melazzini, Nicolino Ambrosino
177 [GO] 2020―Jun―09 SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy Gregorio Paolo Milani, Emanuele Montomoli, Valentina Bollati, Benedetta Albetti, Claudio Bandi, Tommaso Bellini, et al. (+34)
178 [GO] 2020―Jun―07 Need for innovative and timely synthesis of evidence during Covid-19 outbreak Giulio Francesco Romiti, Bernadette Corica, Roberto Cangemi, Stefania Basili, Valeria Raparelli
179 [GO] 2020―Jun―06 PROTECTIVE ROLE OF CHRONIC TREATMENT WITH DIRECT ORAL ANTICOAGULANTS IN ELDERLY PATIENTS AFFECTED BY INTERSTITIAL PNEUMONIA IN COVID-19 ERA Rosario Rossi, Francesca Coppi, Marisa Talarico, Giuseppe Boriani
180 [GO] 2020―Jun―05 COVID-19, a viral endocrinological disease? Tiziana Grassi, Elena Varotto, Francesco M. Galassi
181 [GO] 2020―Jun―04 COVID-19 and hydroxychloroquine: is the wonder drug failing? Ugo Paliani, Andrea Cardona
182 [GO] 2020―Jun―02 COVID-19: The Waterloo of governments, healthcare systems, and large health organizations. Michael Doumas, Konstantinos P. Imprialos, Dimitrios Patoulias, Alexandra Katsimardou, Konstantinos Stavropoulos
183 [GO] 2020―Jun―01 Hepatic consequences of COVID-19 infection. Lapping or biting? Piero Portincasa, Marcin Krawczyk, Antonia Machill, Frank Lammert, Agostino Di Ciaula
184 [GO] 2020―May―28 Active smoking and severity of coronavirus disease 2019 (COVID-19): Differences in measurement of variables could cause errors in the results. Sánchez JJ, Acevedo N, Guzmán E
185 [GO] 2020―May―28 Covid-19 in Italy: lesson from the Veneto Region Giacomo Mugnai, Claudio Bilato
186 [GO] 2020―May―28 Balancing the need for rapid and rigorous scientific data during early phase of the COVID-19 pandemic: A further role for the scientific community Mario Rotondi, Manuel Nieto-Diaz, Flavia Magri, Antonio Oliviero
187 [GO] 2020―May―28 The eighth alternative to Evidence Based Medicine in the early era of the COVID-19 pandemic: too much Emergency and Emotion, too little Evidence. Filippo Pieralli, Vieri Vannucchi, Iacopo Olivotto
188 [GO] 2020―May―28 Does active smoking worsen Covid-19? Alberto Carmona Bayonas, Paula Jimenez-Fonseca, Álvaro Sánchez Arraez, Felipe Álvarez Manceñido, Eduardo Castañón
189 [GO] 2020―May―22 Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study Corrado Campochiaro, Emanuel Della-Torre, Giulio Cavalli, Giacomo De Luca, Marco Ripa, Nicola Boffini, et al. (+10)
190 [GO] 2020―May―21 Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy Valentina Morena, Laura Milazzo, Letizia Oreni, Giovanna Bestetti, Tommaso Fossali, Cinzia Bassoli, et al. (+22)
191 [GO] 2020―May―16 Tocilizumab for severe COVID-19: a promising intervention affecting inflammation and coagulation Marcel Levi
192 [GO] 2020―May―16 Why should we use convalescent plasma for COVID-19? Massimo Franchini
193 [GO] 2020―May―15 Good times, bad times: A diary of a physician in the COVID-19 era Tommaso Lupia, Giacomo Stroffolini, Roberto Angilletta, Stefano Bonora, Giovanni Di Perri
194 [GO] 2020―May―13 Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia Ruggero Capra, Nicola De Rossi, Flavia Mattioli, Giuseppe Romanelli, Cristina Scarpazza, Maria Pia Sormani, Stefania Cossi
195 [GO] 2020―May―08 Active smoking and severity of coronavirus disease 2019 (COVID-19): the use of significance testing leads to an erroneous conclusion Ernest Lo, Benoit Lasnier
196 [GO] 2020―May―07 Bleeding in COVID-19 severe pneumonia: The other side of abnormal coagulation pattern? Clara Benedetta Conti, Sonia Henchi, Giovanni Paolo Coppeta, Sophie Testa, Roberto Grassia
197 [GO] 2020―May―03 Do we know when to end isolation of persons affected with COVID-19? Dror Dicker, Tatiana Kournos, Dana Marcoviciu, Rachel Golan
198 [GO] 2020―May―01 Active smoking and COVID-19: a double-edged sword Giuseppe Lippi, Fabian Sanchis-Gomar, Brandon Michael Henry
199 [GO] 2020―Apr―30 Covid-19 cases in a no-Covid-19 geriatric acute care setting. A sporadic occurrence? Stefano Fumagalli, Bernardo Salani, Luciano Gabbani, Enrico Mossello, Andrea Ungar
200 [GO] 2020―Apr―30 The quality of the reported sample size calculation in clinical trials on COVID-19 patients indexed in PubMed Paul H. Lee
201 [GO] 2020―Apr―23 Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data Paulo Ricardo Martins-Filho, Carolina Santos Souza Tavares, Victor Santana Santos
202 [GO] 2020―Apr―23 Smoking habit and hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related pneumonia: The unsolved paradox behind the evidence. Giovanna Garufi, Luisa Carbognin, Armando Orlandi, Giampaolo Tortora, Emilio Bria
203 [GO] 2020―Apr―23 SARS-CoV-2 detection in the pericardial fluid of a patient with cardiac tamponade Andrea Farina, Giuseppe Uccello, Marta Spreafico, Giorgio Bassanelli, Stefano Savonitto
204 [GO] 2020―Apr―20 The pivotal link between ACE2 deficiency and SARS-CoV-2 infection Paolo Verdecchia, Claudio Cavallini, Antonio Spanevello, Fabio Angeli
205 [GO] 2020―Apr―13 COVID-19: TIMING IS IMPORTANT Giovanni de Simone, Costantino Mancusi
206 [GO] 2020―Apr―08 Is low sodium intake a risk factor for severe and fatal COVID-19 infection? Adrian Post, Robin P.F. Dullaart, Stephan J.L. Bakker
207 [GO] 2020―Mar―16 Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19) Giuseppe Lippi, Brandon Michael Henry
 [1] 

207 Results       Page 1


[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.007 sec